Low Dose Naltrexone (LDN): Frequently Asked Questions (FAQs)
At ScriptWorks Pharmacy, we get tons of questions about Low Dose Naltrexone (LDN) every day.
A Deeper Look into Low Dose Naltrexone (LDN): Research & Insights
Naltrexone is an opiate receptor antagonist. The 50-mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5–9 mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.
Low Dose Naltrexone: A Medical Game Changer
ScriptWorks has spent hours and hours researching and collaborating with healthcare professionals on Low Dose Naltrexone since 2014. Doctors and pharmacists around the world continue to study this fascinating therapy.
Methylene Blue: Evaluating an Old Drug with a New Indication
Lately, our pharmacists have been getting lots of calls about Methylene Blue. I thought we should discuss this in our blog this month.